|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Exercise capacity in obstructive and restrictive pulmonary disease显示文摘 | Lo russo TJ Belmam M Elashoff JD | 1993 | Chest1993，104，： | 1 |
| 2 | Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol显示文摘 | SEHNERT A J DANIELS S E ELASHOFF M | 2008 | J Am Coll Cardiol2008，52，8： | 1 |
| 3 | Pancreatitis, pancreatic, and thyroid cancer with glucagon - like peptide - 1 based therapies 显示文摘 | Elashoff M Matveyenko AV Gier B | 2011 | Gastroenterology2011，141，1： | 1 |
| 4 | Pancreatitis,pancreatic,and thyroid cancer with glucagon-like peptide-1-based therapies显示文摘 | Elashoff M Matveyenko AV Gier B | 2011 | Gastroenterology2011，141，： | 1 |
| 5 | Pancreatitis,pancreatic,and thyroid cancer with glucagon-like peptide-1 based therapies显示文摘 | Elashoff M Matveyenko A V Gier B | 2011 | Gastroenterology2011，141，1： | 1 |
| 6 | , Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients显示文摘 | Rosenberg S Elashoff M R Beineke P | 2010 | Annlnternal Med2010，153，7： | 1 |
| 7 | Panereatitis, pancreatic, and thyroid cancer with glueagon-like peptide-l-based theapies 显示文摘 | Elashoff M Matveyenko AV Gier B | 2011 | Gastroenterology2011，141，1： | 1 |
| 8 | Pancreatitis,pancreatic,and thyroid cancer with glucagon-like peptide-1-based therapies显示文摘 | Elashoff M Matveyenko AV Gier B | 2011 | Gastroenterology2011，141，1： | 1 |
| 9 | Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide- 1-Based Therapies显示文摘 | Elashoff M Matveyenko AV Gier B | 2011 | Gastroenterology2011，141，： | 1 |
| 10 | Cyclooxygenase-2 dependent activa tion of signal transducer and activator of transcription 3 by in terleukin-6 in non-small cell lung cancer 显示文摘 | Dalwadi H Krysan K Heuze-Vourc' h N Dohadwala M Elashoff D Sharma S | 2005 | Clin Cancer Res2005，11，： | 1 |
| 11 | Multi-center validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructivecoro-nary artery disease in nondiabetic patients显示文摘 | Rosenberg S Elashoff M R Beineke P | 2010 | Annals of Internal Medicine2010，153，7： | 1 |
| 12 | Exercise capacity in obstructive and restrictive pulmonary disease显示文摘 | Lo Russo TJ Eelman M Elashoff JD | 1993 | Chest1993，104，： | 1 |
| 13 | Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies 显示文摘 | Elashoff M Matveyenko AV Gier B | 2011 | Gastroenterology2011，141，1： | 1 |
| 14 | Pancreatitis,pancreatic,and thyroid cancer with glucagon-like peptide-1-based therapies显示文摘 | Elashoff M Matveyenko AV Gier B | 2011 | Gastroenterology2011，141，1： | 1 |
| 15 | Pancreatitis,pan-creatic ,and thyroid cancer with glucagon-like peptide-1 -basedtherapies显示文摘 | Elashoff M Matveyenko AV Gier B | 2011 | Gastroenterology2011，141，1： | 1 |
| 16 | A critical analysis ofthe clinical use of incretin-based therapies: are the GLP-1 thera-pies safe? 显示文摘 | Butler PC Elashoff M Elashoff R | 2013 | Diabetes Care2013，36，7： | 1 |
| 17 | Transcriptome analysis of male–female differences in prefrontal cortical development显示文摘 | Weickert CS Elashoff M Richards AB | | 0，，06： | 1 |
| 18 | Mitochondrial DNA variants of respiratory complex Ⅰ that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration显示文摘 | SanGiovanni JP Arking DE Iyengar SK Elashoff M Clemons TE Reed GF | | 0，，05： | 1 |
| 19 | Pancreati- tis, pancreatic, and thyroid cancer with glucagon-like peptide-1- basedtherapies显示文摘 | ELASHOFF M MATVEYENKO AV GIER B | 2011 | Gastroenterology2011，141，1： | 1 |
| 20 | Missing observations in multivariate statistics I: Review of the literature显示文摘 | Afifi A A Elashoff R M | 1966 | Journal of the American Statistical Association1966，61，315： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员